ES2192608T3 - Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas. - Google Patents

Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.

Info

Publication number
ES2192608T3
ES2192608T3 ES96924889T ES96924889T ES2192608T3 ES 2192608 T3 ES2192608 T3 ES 2192608T3 ES 96924889 T ES96924889 T ES 96924889T ES 96924889 T ES96924889 T ES 96924889T ES 2192608 T3 ES2192608 T3 ES 2192608T3
Authority
ES
Spain
Prior art keywords
infection
alilamine
terbinafine
derivatives
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96924889T
Other languages
English (en)
Inventor
Ivan James Dalton Lindley
Neil Stewart Ryder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2192608T3 publication Critical patent/ES2192608T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)

Abstract

USO DE COMPUESTOS DE FORMULA (I), EN QUE R TIENE VARIOS SIGNIFICADOS, EN FORMA DE BASE LIBRE O EN FORMA DE SAL FARMACEUTICAMENTE ACEPTABLE, COMO AGENTES CONTRA LA INFECCION POR H. PYLORI Y ENFERMEDADES ASOCIADAS.
ES96924889T 1995-07-06 1996-07-05 Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas. Expired - Lifetime ES2192608T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9513750.1A GB9513750D0 (en) 1995-07-06 1995-07-06 Use of allylamines

Publications (1)

Publication Number Publication Date
ES2192608T3 true ES2192608T3 (es) 2003-10-16

Family

ID=10777201

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96924889T Expired - Lifetime ES2192608T3 (es) 1995-07-06 1996-07-05 Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.

Country Status (27)

Country Link
US (1) US5935998A (es)
EP (1) EP0863752B1 (es)
JP (1) JP3680950B2 (es)
KR (1) KR100425401B1 (es)
CN (1) CN1204881C (es)
AT (1) ATE232723T1 (es)
AU (1) AU715270B2 (es)
CA (1) CA2219678C (es)
CY (1) CY2465B1 (es)
CZ (1) CZ289440B6 (es)
DE (1) DE69626301T2 (es)
DK (1) DK0863752T3 (es)
ES (1) ES2192608T3 (es)
GB (1) GB9513750D0 (es)
HK (1) HK1011527A1 (es)
HU (1) HU224311B1 (es)
IL (1) IL122853A (es)
MX (1) MX9710093A (es)
MY (1) MY132436A (es)
NO (1) NO317496B1 (es)
PL (1) PL187704B1 (es)
RU (1) RU2193402C2 (es)
SI (1) SI0863752T1 (es)
SK (1) SK282874B6 (es)
TW (1) TW522011B (es)
WO (1) WO1997002026A1 (es)
ZA (1) ZA965749B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) * 2002-02-05 2003-08-09 한솔케미언스 주식회사 (ｅ)-터비나핀 또는 이의 염산염의 제조방법
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) * 1979-06-08 1980-12-18 Sandoz Ag 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
DE4317449A1 (de) * 1993-05-19 1994-11-24 Asche Ag Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

Also Published As

Publication number Publication date
GB9513750D0 (en) 1995-09-06
HUP9802929A3 (en) 1999-10-28
EP0863752B1 (en) 2003-02-19
MX9710093A (es) 1998-03-31
ZA965749B (en) 1998-01-05
WO1997002026A1 (en) 1997-01-23
CN1204881C (zh) 2005-06-08
CN1189775A (zh) 1998-08-05
JPH11508580A (ja) 1999-07-27
NO317496B1 (no) 2004-11-08
IL122853A0 (en) 1998-08-16
AU715270B2 (en) 2000-01-20
RU2193402C2 (ru) 2002-11-27
ATE232723T1 (de) 2003-03-15
PL323305A1 (en) 1998-03-16
SI0863752T1 (en) 2003-06-30
CZ1798A3 (cs) 1998-03-18
EP0863752A1 (en) 1998-09-16
CA2219678C (en) 2006-10-10
KR100425401B1 (ko) 2004-07-16
PL187704B1 (pl) 2004-09-30
HUP9802929A2 (hu) 1999-09-28
NO975790D0 (no) 1997-12-09
TW522011B (en) 2003-03-01
SK282874B6 (sk) 2003-01-09
DK0863752T3 (da) 2003-04-22
JP3680950B2 (ja) 2005-08-10
NO975790L (no) 1997-12-09
CZ289440B6 (cs) 2002-01-16
HU224311B1 (hu) 2005-07-28
DE69626301T2 (de) 2003-10-16
DE69626301D1 (de) 2003-03-27
IL122853A (en) 2001-04-30
AU6519596A (en) 1997-02-05
KR19990028725A (ko) 1999-04-15
CA2219678A1 (en) 1997-01-23
CY2465B1 (en) 2005-06-03
SK698A3 (en) 1998-05-06
MY132436A (en) 2007-10-31
US5935998A (en) 1999-08-10
HK1011527A1 (en) 1999-07-16

Similar Documents

Publication Publication Date Title
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
SE9904505D0 (sv) Novel compounds
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
PA8432901A1 (es) Compuestos de piridilpirrol
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
BR0113590A (pt) 7-oxo-piridopirimidinas
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
AR021086A1 (es) Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento.
ES2192608T3 (es) Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.
ES2194129T3 (es) Compuestos farmaceuticos.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
DE60214476D1 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung anbieten
CO4700299A1 (es) Derivados de piperazina, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments